A Phase I Trial of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-HIV Ribozyme
- 1 September 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 10 (13) , 2255-2270
- https://doi.org/10.1089/10430349950017239
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDSSeminars in Immunology, 1996
- Transfer of an Anti-HIV-1 Ribozyme Gene into Primary Human LymphocytesHuman Gene Therapy, 1994
- The Development and Testing of Retroviral Vectors ExpressingTrans-Dominant Mutants of HIV-1 Proteins to Confer Anti-HIV-1 ResistanceHuman Gene Therapy, 1993
- Cells Induced to Express a Human Immunodeficiency Virus Type 1 Envelope Gene Mutant Inhibit the Spread of Wild-Type VirusHuman Gene Therapy, 1992
- The potential use of catalytic RNAs in therapy of HIV infection and other diseasesPharmacology & Therapeutics, 1991
- SCID mice as immune system modelsCurrent Opinion in Immunology, 1991
- Lymphoid reconstitution of the human fetal thymus in SCID mice with CD34+ precursor cells.The Journal of Experimental Medicine, 1991
- The biology of long-term bone marrow cultures and its application to bone marrow transplantationCurrent Opinion in Oncology, 1991
- Inhibition of heterologous strains of HIV by antisense RNAAIDS, 1991
- Hematopoietic Stem CellsNew England Journal of Medicine, 1979